Ron Mazumder

Ron brings almost thirty years of experience working with biomarkers, technologies, and computational approaches for pharmaceutical and diagnostics programs.

After leading the development of genomics technologies and novel platforms for several biotech companies, Ron worked for Johnson and Johnson and Merck, where he developed diagnostics and companion diagnostics, pharmacodynamic and predictive biomarkers. Most recently, Ron was Vice President and Global Head of Oncology Biomarker Development and Companion Diagnostics at Genentech.

He obtained his B.A. from The Johns Hopkins University, his PhD from the University of Maryland, and his MBA from Lehigh University.